Correlation Between Scpharmaceuticals and Oruka Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Oruka Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Oruka Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Oruka Therapeutics,, you can compare the effects of market volatilities on Scpharmaceuticals and Oruka Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Oruka Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Oruka Therapeutics,.
Diversification Opportunities for Scpharmaceuticals and Oruka Therapeutics,
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Scpharmaceuticals and Oruka is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Oruka Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oruka Therapeutics, and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Oruka Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oruka Therapeutics, has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Oruka Therapeutics, go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Oruka Therapeutics,
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 1.1 times more return on investment than Oruka Therapeutics,. However, Scpharmaceuticals is 1.1 times more volatile than Oruka Therapeutics,. It trades about -0.25 of its potential returns per unit of risk. Oruka Therapeutics, is currently generating about -0.41 per unit of risk. If you would invest 437.00 in Scpharmaceuticals on August 27, 2024 and sell it today you would lose (102.00) from holding Scpharmaceuticals or give up 23.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Oruka Therapeutics,
Performance |
| Timeline |
| Scpharmaceuticals |
| Oruka Therapeutics, |
Scpharmaceuticals and Oruka Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Oruka Therapeutics,
The main advantage of trading using opposite Scpharmaceuticals and Oruka Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Oruka Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will offset losses from the drop in Oruka Therapeutics,'s long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Oruka Therapeutics, vs. Eliem Therapeutics | Oruka Therapeutics, vs. HCW Biologics | Oruka Therapeutics, vs. Scpharmaceuticals | Oruka Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |